Member Info for cl81227

Wholly agree, but the fundamentals of the company havent changed, even though, the sale by FAB has clearly spooked the market and caused the sell off.

Short term this is frustrating for a LT Investor like myself. And unfortunately this is part and parcel of being invested in a company where TB is involved. Says one thing one week and does something completely at odds the following. Just keep in mind, we have no idea what his thinking was regarding that sale, he clearly knew that TR1 would have had this effect, in the grand scheme of things, he still holds a huge % of the company, and the mark down looks a bit overdone, but that's penny shares for you. But at the end of the day, with all the sales, someone is buying , keep that in mind.

Is it possible 10% was released in order to let somebody else in. If so should see another TR1 soon. We know from experience, there's very little liquidity normally.

Who or what is FAB exactly

I would hardly call that a sell off, most of those sells, are literally peanuts in the grand scheme of things

It's not a pump and dump stock. Following GE deal this has very much de risked now. And with a great and wide portfolio, massively undervalued.

If anyone is buying for the short term, then unfortunately it's prone to sudden MM manipulations and trader sell offs. But those with a long term approach, will hopefully be rewarded as its way undervalued at these levels

Still Peanuts 😁

Agree TREK, only a matter of time b4 market and daresay some institutions finally realise what's been completely overlooked and massively undervalued here and we get the appropriate re rate and that's just for starters. If the numerous projects start to gain further approval and traction, then who knows where this could go.

Hi Trek, is this possibly an interim approval,namely 50% before we get final 100% Gd free come through. Even so at 50%, this is still a substantial improvement, both on safety and costs. I'm sure this time round with our recently announced GE deal, they will look to exploit this UPS massively. As for the wider market not getting this massively undervalued company, as frustrating as it is for us LT investors, I'm sure the medical industry are much more aware now and with everthing in our locker, it's only a matter of time, before something stellar happens, which we all know what that might mean.

Ditto- completely agree with all the recent posts. The GE deal putts us in a great place now and that's even the half of it, when it comes to our fabulous overall portfolio. At this Mcap, expect a serious rerate anytime soon, and not talking pennies. I'm with you Trek, my bottom drawer is securely locked until we get to 0.50p, which isn't unreasonable . Where we go after that is anybody guess. Just ignore the daily noise and traders dipping in and out along the way .

Hi Trek , still peanuts at these low prices. The large daily % gains are irrelevant when we are down here. True value way over 10p, so don't let MM's steal these at anything less than 10 to 15 p and if takeover on the cards, suggest much more.

Agreed, traders in and out for a quick profit. Patience will be rewarded, just tuck em away and don't get focussed on daily price movements. At this modest Mcap, there is real long term value here. It will come.

Totally agree Trek. Difficult to pinpoint exactly where this could end up as so many plays/outcomes could appear or be taken from us along the way. Like you, I have been slowly adding over the past few years and a decent stake now tucked away. Would like to see somewhere in the region 2-300m M Cap achieved before they get prized from me.

Market cap of still only 7m, with so many strings to its bow. It will only be a matter of time before the wider market gets wind of this company, and with such a small free float, a major re-rate will be on the cards. Unfortunately the day traders will turn up, some of whom will look to destabilise the BB for their own ends, but he ho I can live with that.

Oops - silly me meant Wisconsin !!

Really please to see upbeat announcement today. Financials and losses unbelievably low, when you think what the company has embarked on. It wasn't lost on me either the subtle reference to increased exposure on US TV on our phase 1 progress. I can't believe with all that we have we still only have an M cap around ~£5m. Its absolutely crazy. I dare say a big Pharma CEO could buy us out with petty cash or expenses, which of course can't happen without agreement of the board. I wouldn't be surprised if we have already had approaches, but TB and board would know, that much more value to be derived, once we hopefully move from Phase 1 into 2. Once a serious offer is forthcoming, then fully expect a takeover for significantly more than where we are now, maybe 100-200M. Its great that there is very little free float in this stock and major holders including Kathrine at Milwaukee, will ensure that this doesn't go for peanuts, given all their hard work. Ive been steadily accumulating at these very low levels and tucking them away, with the confidence that at some point in the future, this will have its day in the sun. GLA

Confirmation of rollout of AI into 9 nhs. 9 platforms approved. Can't see us in that list though.

https://www.theguardian.com/society/2023/aug/11/nice-recommends-use-of-ai-in-nhs-radiotherapy-treatment-in-england

What so they mislead the market by saying they have applied to the fda to run mri scans in the absence of the gandolinium contrast agent, in the midst of a worldwide shortage. I don't think so. Huge upside and uptake if this gets approval

Omega Diagnostics

@OmegaDiagnostic

· Jun 8

We're also excited to announce that our technology partner, @mologic, has successfully completed the necessary performance studies required for regulatory approval in the USA.

Thanks 1509, for the record, i have been an avid follower of this board for some time, originally from following EVA in SNG abd VAL, although I choose not to post, I think it's a great achievement that this is a home for sebsible debate and no personal abuse that you usually find on most share boards. Why investing should attract so many nut jobs is beyond me.
In terms of the Innova news today, I would imagine that all UK diagnostic companies will benefit. Possibly RTC consortium members most. AVCT there is
a strong rumour that their test will be the DHSC gold standard, with a tie up with Moligic and ODX.
Mologic own visitec antigen lft, we know are applying for FDA approval and are backed by Bill Gates foundation, it does have good credentials as well, so this could gain rapid approval as well as becoming the UK sovereign test, particularly if AVCT runs into delays.
ODX are manufacturing for Mologic so could be hugely beneficial. Suspect ODX to rerate positively in the coming days, started today and will continue tomorrow based on the Innova news after market closed today.

Hi 1509, yes FDA just advised public not to use Innova test as its dangerous due to innacuracies. Productc 1 recall in effect. They have also issued Innova with a warning letter.

hTTps://www.einnews.com/pr_news/543484341/stop-using-innova-sars-cov-2-antigen-rapid-qualitative-test-fda-safety-communication